Do traditional VT zones improve outcome in primary prevention ICD patients?

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 11, 2010, Pages 1353-1358

  Duncan, Edward ^a   Thomas, Glyn ^a   Johns, Neville ^a   Pfeffer, Cameron ^a   Appanna, Gautham ^a   Shah, Nirav ^a   Hunter, Ross ^a   Finlay, Malcolm ^a   Schilling, Richard J ^a   Sporton, Simon ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

ATP; ICD; primary prevention; shocks; zone

Indexed keywords

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIAC PATIENT; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART ASSIST DEVICE; HEART BEAT; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SHOCK;

AGED; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; STROKE VOLUME; TACHYCARDIA, SUPRAVENTRICULAR; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 78349291866     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02859.x     Document Type: Article

References (7)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al,. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, et al,. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
3. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, et al,. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002; 105: 589-594.
4. Kamphuis HC, De Leeuw JR, Derksen R, Hauer RN, Winnubst JA,. Implantable cardioverter defibrillator recipients: Quality of life in recipients with and without ICD shock delivery: A prospective study. Europace 2003; 5: 381-389.
5. Tzeis S, Andrikopoulos G, Kolb C, Vardas PE,. Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. Europace 2008; 10: 1256-1265.
6. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, et al,. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365.
7. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, et al,. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004; 110: 2591-2596.